RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biocorp Production - Stock

Biocorp Production EBIT 2024

Biocorp Production EBIT

2.47 M EUR

Ticker

ALCOR.PA

ISIN

FR0012788065

WKN

A14V4G

In 2024, Biocorp Production's EBIT was 2.47 M EUR, a 220% increase from the 772,500 EUR EBIT recorded in the previous year.

The Biocorp Production EBIT history

YEAREBIT (undefined EUR)
2026e49.65
2025e4.12
2024e2.47
2023e0.77
2022-0.73
20210.14
2020-1.61
20190.88
2018-5.27
2017-7.85
2016-4.66
2015-3.2
2014-2.57
2013-0.49
2012-0.32

Biocorp Production Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Biocorp Production, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Biocorp Production from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Biocorp Production’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Biocorp Production. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Biocorp Production’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Biocorp Production’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Biocorp Production’s growth potential.

Biocorp Production Revenue, Profit, and EBIT History

DateBiocorp Production RevenueBiocorp Production EBITBiocorp Production Net Income
2026e61.42 M undefined49.65 M undefined52.13 M undefined
2025e29.97 M undefined4.12 M undefined3.72 M undefined
2024e22.87 M undefined2.47 M undefined1.63 M undefined
2023e15.14 M undefined772,500 undefined45,346.43 undefined
202211.67 M undefined-732,100 undefined-651,180 undefined
202110.23 M undefined137,400 undefined294,230 undefined
20208.46 M undefined-1.61 M undefined-1.24 M undefined
20198.45 M undefined875,020 undefined959,780 undefined
20183.89 M undefined-5.27 M undefined-5.31 M undefined
20172.32 M undefined-7.85 M undefined-7.51 M undefined
20162.95 M undefined-4.66 M undefined-4.45 M undefined
20152.46 M undefined-3.2 M undefined-851,070 undefined
20141.65 M undefined-2.57 M undefined0 undefined
20132.03 M undefined-490,000 undefined400,000 undefined
20122.02 M undefined-320,000 undefined0 undefined

Biocorp Production stock margins

The Biocorp Production margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biocorp Production. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biocorp Production.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Biocorp Production's sales revenue. A higher gross margin percentage indicates that the Biocorp Production retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Biocorp Production's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Biocorp Production's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Biocorp Production's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Biocorp Production. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Biocorp Production's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Biocorp Production Margin History

Biocorp Production Gross marginBiocorp Production Profit marginBiocorp Production EBIT marginBiocorp Production Profit margin
2026e91.16 %80.84 %84.88 %
2025e91.16 %13.75 %12.41 %
2024e91.16 %10.81 %7.14 %
2023e91.16 %5.1 %0.3 %
202291.16 %-6.27 %-5.58 %
202197.25 %1.34 %2.88 %
202090.55 %-18.98 %-14.69 %
2019101.77 %10.36 %11.36 %
201879.79 %-135.43 %-136.37 %
201791.23 %-338.05 %-323.5 %
201677.27 %-158.11 %-150.76 %
201558.3 %-129.97 %-34.56 %
201476.97 %-155.76 %0 %
201376.85 %-24.14 %19.7 %
201279.21 %-15.84 %0 %

Biocorp Production Aktienanalyse

What does Biocorp Production do?

Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Biocorp Production's EBIT

Biocorp Production's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Biocorp Production's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Biocorp Production's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Biocorp Production’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Biocorp Production Stock

How much did Biocorp Production achieve in EBIT for the current year?

In the current year, Biocorp Production has achieved an EBIT of 2.47 M EUR.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Biocorp Production.

How has the EBIT of Biocorp Production developed in recent years?

The EBIT of Biocorp Production has increased by 220% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Biocorp Production?

The EBIT of Biocorp Production is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Biocorp Production pay?

Over the past 12 months, Biocorp Production paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biocorp Production is expected to pay a dividend of 0 EUR.

What is the dividend yield of Biocorp Production?

The current dividend yield of Biocorp Production is .

When does Biocorp Production pay dividends?

Biocorp Production pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biocorp Production?

Biocorp Production paid dividends every year for the past 0 years.

What is the dividend of Biocorp Production?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biocorp Production located?

Biocorp Production is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biocorp Production kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biocorp Production from 6/27/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Biocorp Production pay the last dividend?

The last dividend was paid out on 6/27/2024.

What was the dividend of Biocorp Production in the year 2023?

In the year 2023, Biocorp Production distributed 0 EUR as dividends.

In which currency does Biocorp Production pay out the dividend?

The dividends of Biocorp Production are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biocorp Production

Our stock analysis for Biocorp Production Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biocorp Production Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.